Consonance Capital Management as of March 31, 2022
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 8 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tandem Diabetes Care Com New (TNDM) | 29.1 | $17M | 147k | 116.29 | |
| Silence Therapeutics Ads (SLN) | 21.1 | $12M | 654k | 19.00 | |
| Surrozen | 17.9 | $11M | 3.5M | 3.01 | |
| Globus Med Cl A (GMED) | 13.4 | $7.9M | 107k | 73.78 | |
| Compass Therapeutics (CMPX) | 8.0 | $4.7M | 3.5M | 1.36 | |
| United Therapeutics Corporation (UTHR) | 7.5 | $4.4M | 25k | 179.42 | |
| Helix Acquisition Corp Com Cl A | 2.6 | $1.5M | 137k | 11.10 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.5 | $291k | 1.2M | 0.25 |
